Nanotechnology contributions to the pharmacotherapy of pediatric HIV: a dual scientific and ethical challenge and a still pending agenda

A Highly Concentrated and Taste-Improved Aqueous Formulation of Efavirenz for a More Appropriate Pediatric Management of the Anti-HIV Therapy

(2010) Diego A. Chiappetta et al.   CURRENT HIV RESEARCH

Nanotechnology solutions for infectious diseases in developing nations

(2009) Alejandro Sosnik et al.   ADVANCED DRUG DELIVERY REVIEWS

Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations

(2009) Matthijs van Luin et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice

(2009) M. Fabbiani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability

(2009) Diego A Chiappetta et al.   Nanomedicine

Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children

(2008) U. Wintergerst et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY